A recent $50 million wrongful‑death verdict in Alabama centers on a scenario familiar to cardiologists: a symptomatic patient with high‑risk unstable angina, a significant coronary lesion documented on catheterization, and a decision to discharge rather than admit and treat. Expert testimony suggested that with standard inpatient management and antithrombotic therapy, the patient’s likelihood of survival would have been extremely high, underscoring how preventable this outcome likely was.
High‑risk unstable angina within the NSTE‑ACS spectrum
Clinically, this case fits high‑risk unstable angina within the non‑ST‑elevation acute coronary syndrome (NSTE‑ACS) spectrum: days of chest and interscapular pain, exertional symptoms, and an angiographically significant coronary lesion, without any description of ST‑segment elevation. Current ESC and ACC/AHA guidance manage high‑risk unstable angina and NSTEMI similarly, emphasizing admission, antithrombotic therapy, and an early invasive strategy in patients with ongoing ischemia or high‑risk features.
The 2020 ESC NSTE‑ACS guidelines, for example, recommend an early invasive strategy (within 24 hours) for patients with high‑risk features such as dynamic ST‑T changes, elevated troponin, GRACE score >140, or ongoing/recurrent ischemia. A symptomatic patient with a clearly significant coronary lesion on cath almost certainly meets a high‑risk threshold and is difficult to justify as a routine same‑day discharge.
The post‑cath inflection point
The critical clinical decision was what happened after the significant lesion was documented on catheterization. In a patient with high‑risk unstable angina, guideline‑concordant care typically involves inpatient monitoring, dual antiplatelet therapy, parenteral anticoagulation, and timely revascularization within an early invasive strategy framework.
Instead, the patient was discharged, cleared for an imminent elective eye surgery, and reportedly advised to defer starting blood thinners until after that procedure. That sequence effectively prioritized a noncardiac elective operation over stabilizing an unstable coronary substrate, which is difficult to reconcile with ACS guidance that places immediate ischemic risk above nonurgent surgery.
How protocol drift creeps in
Several elements of protocol drift are recognizable in this case.
• Persistent chest and back pain with dyspnea over several days was not consistently treated as ongoing ischemia in a high‑risk unstable angina framework.
• Scheduling pressure around an elective ophthalmologic procedure appears to have influenced decision‑making more than the near‑term risk of myocardial infarction or sudden death.
• Post‑cath disposition seems to have occurred outside a structured NSTE‑ACS pathway that would default to admission and early invasive management for high‑risk unstable angina.
Both ESC and ACC/AHA guidance stress that high‑risk NSTE‑ACS, including high‑risk unstable angina, should not be managed as “stable” disease. These patients carry substantial short‑term event risk and are expected to remain hospitalized until adequately treated.
Documentation, guidelines, and credibility
From a medicolegal standpoint, the case also underscores the centrality of contemporaneous documentation. The jury appears to have relied heavily on the clinic’s own records, including the cardiologist’s notes describing symptoms, findings, and the discharge plan. The defense position required challenging or re‑interpreting those same records, which jurors understandably perceived as undermining credibility rather than clarifying nuance.
When management deviates from what ACS guidelines and institutional pathways would predict—such as discharging a patient with high‑risk unstable angina and a significant lesion—the rationale must be explicitly documented: diagnostic uncertainty, specific patient preferences, procedural constraints, or competing risks. Without that, any attempt to reconstruct the reasoning later risks sounding like litigation‑driven revisionism rather than real‑time clinical judgment.
Practical takeaways for cardiology teams
For cardiologists, fellows, and service leaders, this case is a prompt to stress‑test local ACS processes:
• Ensure NSTE‑ACS/unstable angina pathways clearly define high‑risk criteria and strongly default to admission, antithrombotic therapy, and early invasive management when they are present.
• Treat post‑cath disposition for high‑risk unstable angina as a high‑stakes decision point, not a routine checkbox; any decision to discharge should be an exception with clear documentation.
• Make explicit that noncardiac elective procedures never supersede short‑term ACS risk—when in doubt, delay the eye surgery, not the ACS management.
• Teach trainees that adherence to Class I recommendations for high‑risk NSTE‑ACS (including high‑risk unstable angina) is both a patient‑safety and risk‑management strategy, improving outcomes and making care easier to defend if later scrutinized.
Cases like this are devastating for families and emotionally taxing for clinicians. The constructive response is not to practice reflexively defensive medicine, but to tighten our alignment between risk recognition, guideline‑based unstable angina care, and what actually happens at the bedside.
References
1. MDLinx. “$50 million for cardiology protocol failure: Where did the decision-making break down?” March 23, 2026.[mdlinx]
2. Collet J‑P, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST‑segment elevation. Eur Heart J. 2021;42(14):1289‑1367.[academic.oup +2]
3. ESC Council for Cardiology Practice. “2020 ESC NSTE‑ACS Guidelines: Key Points.” European Society of Cardiology website.[acc +1]
4. ACC/AHA/ACEP/NAEMSP/SCAI Guideline‑related resources on ACS and NSTE‑ACS. American Heart Association / American College of Cardiology professional pages.[ahajournals +1]
5. LITFL. “NSTEACS Management.” Critical Care Compendium.[litfl]
